BELLUS Health Inc.

LSE:0A4U 株式レポート

時価総額:CA$2.5b

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

BELLUS Health 将来の成長

Future 基準チェック /26

We currently don't have sufficient analyst coverage to forecast growth and revenue for BELLUS Health.

主要情報

46.1%

収益成長率

41.4%

EPS成長率

Biotechs 収益成長36.5%
収益成長率69.0%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日16 Jun 2023

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

LSE:0A4U - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202540-147-110-643
12/31/20240-141-130-1273
12/31/20230-117-125-1012
3/31/20230-87-89-89N/A
12/31/20220-76-77-77N/A
9/30/20220-73-68-68N/A
6/30/20220-71-64-64N/A
3/31/20220-70-60-60N/A
12/31/20210-71-61-61N/A
9/30/20210-64-49-49N/A
6/30/20210-47-40-40N/A
3/31/20210-37-36-36N/A
12/31/20200-32-30-30N/A
9/30/20200-34-30-30N/A
6/30/20200-35-32-32N/A
3/31/20200-33-29-29N/A
12/31/20190-26-21-21N/A
9/30/20190-18-14-14N/A
6/30/20190-14-9-9N/A
3/31/20190-9-8-8N/A
12/31/20180-7-7-7N/A
9/30/20180-6-7-7N/A
6/30/20180-5-6-6N/A
3/31/20180-4-5-5N/A
12/31/20170-1-5-3N/A
9/30/20170-1-4-3N/A
6/30/201710-3-2N/A
3/31/201710-3-2N/A
12/31/20161-2N/A-2N/A
9/30/20163-1N/A-2N/A
6/30/201630N/A-2N/A
3/31/201630N/A-2N/A
12/31/201530N/A-2N/A
9/30/201520N/A-2N/A
6/30/20152-1N/A-2N/A
3/31/20152-1N/A-2N/A
12/31/20142-2N/A-3N/A
9/30/20142-2N/A-3N/A
6/30/20142-1N/A-4N/A
3/31/20142-1N/A-3N/A
12/31/20132-1N/A-3N/A
9/30/20132-1N/A-3N/A
6/30/20132-2N/A-3N/A
3/31/20132-10N/A-3N/A
12/31/20122-13N/A-3N/A
9/30/20123-15N/A-2N/A
6/30/20123-14N/A-2N/A

アナリストによる今後の成長予測

収入対貯蓄率: 0A4U is forecast to remain unprofitable over the next 3 years.

収益対市場: 0A4U is forecast to remain unprofitable over the next 3 years.

高成長収益: 0A4U is forecast to remain unprofitable over the next 3 years.

収益対市場: 0A4U's revenue (69% per year) is forecast to grow faster than the UK market (4.5% per year).

高い収益成長: 0A4U's revenue (69% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if 0A4U's Return on Equity is forecast to be high in 3 years time


成長企業の発掘